Research and trials

How exactly do you create an exhibition looking at the hugely complex and emotive subject of cancer? You do exactly what the Science Museum has done in its superb exhibition, which I had the pleasure of attending last month.

We speak with two science communication masters about the benefits, ethics and sheer fun of communicating your research to the public.

On LGBTQ+ STEM day, we hear from two Cancer Research UK scientists on the power of diversity and why bringing your full self to your research is so important…

We’ve partnered with In2science UK, an organisation that promotes diversity in STEM, to sponsor 10 young people through a mentoring programme.

Professor Eithne Costello on the challenges of ambitious trials, the evolution of early detection as a field in its own right and why a guiding framework is all important.

Pioneering therapeutics targeting the damage repair mechanism of DNA polymerase theta in a range of cancers have entered human trials – we tell the story from discovery to translation.

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…